Standard BioTools Inc. (LAB) stock
LABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 12/3087% below fair value
$0.57+0.03 (+5.67%)
Close on Nov 18, 2026Market cap $223.77MP/E 2.6Yield –
Standard BioTools pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Standard BioTools's pe ratio was 2.9× on Nov 11, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.9× | – |
See a number that looks wrong?